Literature DB >> 1594585

Constitutive synthesis of tumor necrosis factor in the thymus.

B P Giroir1, T Brown, B Beutler.   

Abstract

Although tumor necrosis factor (TNF) is a major mediator of endotoxic shock, the normal function of TNF that has preserved this protein throughout mammalian evolution remains unknown. If the protein serves a role in normal development or homeostasis, it must be produced under physiologic conditions. To determine whether TNF secretion occurs in normal animals, and to define the tissue sources of the protein, we prepared a reporter construct in which the TNF coding sequence and introns are replaced by the chloramphenicol acetyltransferase (CAT) coding sequence. This construct was inserted into the murine genome, yielding 13 transgenic founders. Macrophages harvested from 4 of the transgenic lines expressed CAT activity after stimulation with Escherichia coli lipopolysaccharide in vitro. Each of these 4 transgenic lines also constitutively expressed CAT activity in the thymus but in no other tissue examined. Cultured thymocytes secrete TNF, as demonstrated both by cytotoxicity assays and by immunoprecipitation of radiolabeled thymic culture medium. CAT activity was associated with the thymic lymphocyte population and not with thymic macrophages or dendritic cells. CAT activity was present in thymic lymphocytes irrespective of CD4 or CD8 expression; T cells from the spleen, however, had no detectable CAT activity. The biosynthesis of TNF in the thymus of normal animals implies a role for this protein in the development or regulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594585      PMCID: PMC49188          DOI: 10.1073/pnas.89.11.4864

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  A simple method for inducing tolerance of skin homografts in mice.

Authors:  R E BILLINGHAM; L BRENT
Journal:  Transplant Bull       Date:  1957-04

2.  Immunological function of the thymus.

Authors:  J F MILLER
Journal:  Lancet       Date:  1961-09-30       Impact factor: 79.321

3.  Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice.

Authors:  A Kojima; Y Tanaka-Kojima; T Sakakura; Y Nishizuka
Journal:  Lab Invest       Date:  1976-06       Impact factor: 5.662

4.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

5.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

Authors:  V Kruys; K Kemmer; A Shakhov; V Jongeneel; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

7.  Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein.

Authors:  K Cseh; B Beutler
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

8.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.

Authors:  K Peppel; D Crawford; B Beutler
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

2.  Analysis of tumor necrosis factor promoter responses to ultraviolet light.

Authors:  F Bazzoni; V Kruys; A Shakhov; C V Jongeneel; B Beutler
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 3.  The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.

Authors:  T Darville; B Giroir; R Jacobs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

4.  Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1.

Authors:  H Akatsuka; K Imanishi; K Inada; H Yamashita; M Yoshida; T Uchiyama
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

5.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

6.  Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

Authors:  Ava J Wu; Hong Hua; Sibyl H Munson; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

7.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Authors:  Y Harel; M Silva; B Giroir; A Weinberg; T B Cleary; B Beutler
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.

Authors:  Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.